Form 4: Director Ronald Andrews Reports RSU Vesting at Plus Therapeutics

Ronald Andrews, a Director at Plus Therapeutics, Inc., reported the vesting of 922 Restricted Stock Units (RSUs) on July 1, 2026, as per SEC Form 4 filing.

Summary

• Director Ronald Andrews reported a transaction on July 1, 2026.
• The transaction involved the vesting of 922 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of the issuer's Common Stock.
• The vesting occurred as part of a grant that vests in four substantially equal quarterly installments starting July 1, 2026.
• Following this transaction, Mr. Andrews beneficially owns 922 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction (RSU vesting) without providing new financial performance data or strategic updates.

Positives

• Vesting of stock units indicates continued commitment and potential alignment of interests between management and shareholders.
• The RSU grant structure suggests a performance-based incentive for the director.

Future Outlook

The filing details the vesting of RSUs, which is a past event. No specific forward-looking financial guidance or outlook is provided in this Form 4.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive and director compensation and ownership. The vesting of RSUs is a common incentive mechanism in the biotechnology and pharmaceutical sectors, aligning executive interests with long-term company performance.

Stakeholder Impact

• Shareholders: Increased transparency into director compensation and potential increase in shares held by a director.
• Employees: May reflect standard compensation practices within the company.
• Management: Confirms the ongoing incentive structure for directors.

Key Dates

Keywords

Form 4, SEC Filing, Plus Therapeutics, PSTV, Ronald Andrews, Director, Restricted Stock Units, RSU Vesting, Beneficial Ownership, Stock Compensation